期刊文献+

间充质干细胞和Stro-1^+亚群免疫抑制的比较及IDO1、IDO2在其中的作用 被引量:2

Comparison of immunosuppression between MSC and Stro-1^+ MSC and the role of IDO1 and IDO2 in the effect
下载PDF
导出
摘要 目的:比较间充质干细胞(MSC)和经Stro-1抗体分选的Stro-1+MSC对淋巴细胞增殖反应的影响;探讨吲哚胺2,3二氧化酶1(IDO1)和IDO2在上述两种间充质干细胞免疫调节功能中的作用。方法:从全髋关节置换术患者的近端股骨粉碎物中得到细胞悬液,培养MSC,并筛选Stro-1+MSC。体外设立单向混合淋巴细胞反应(MLR)体系,分别加入1×103~5×104个经照射的Stro-1+MSC或MSC,检测对T淋巴细胞增殖反应的影响。再分别加入IDO1和IDO2的特异性抑制剂L-1MT和D-1MT,检测T淋巴细胞增殖反应的变化;以实时定量PCR法比较IDO1、IDO2在Stro-1+MSC和MSC中的表达,以GAPDH作为内参照基因。结果:(1)不同剂量组,Stro-1+MSC对MLR的抑制效应均显著强于相同剂量的未经分选的MSC(P<0.05);(2)加入L-1MT后,Stro-1+MSC和MSC对MLR的抑制作用均显著减弱(P<0.05),而加入D-1MT后Stro-1+MSC和MSC对MLR的抑制作用与未加入抑制剂的对照组相比无显著变化(P>0.05);(3)加入L-1MT后,Stro-1+MSC和MSC对MLR抑制的显著差异不复存在(P>0.05),加入D-1MT后Stro-1+MSC对MLR的抑制作用仍显著强于未经分选的MSC(P<0.05);(4)实时定量PCR检测发现IDO1在Stro-1+MSC中的表达显著高于MSC(P<0.05),而IDO2的表达在两者间无差异(P>0.05)。结论:IDO1在MSC的免疫调节和Stro-1+MSC的强势抑制功能中发挥重要作用,该作用可被IDO1的特异性抑制剂L-1MT所抑制,而IDO2的特异性抑制剂D-1MT无此作用。 Objective: To compare the immunosuppressive effect between mesenchymal stem cells (MSC) and Stro-1 positive subset and detect the role of indoleamine 2,3-dioxygenasel (IDOl) and IDO2 in their effects. Methods: MSC were isolated and cultured from proxi- mal femur marrow of patients undergoing hip replacement, Stro-1 positive cells were sorted out. 1×103^-5×10^4 irradiated Stro-1 + MSC or MSC were added into mixed lymphocyte reaction (MLR) , the proliferation of T lymphocytes was measured. L-1MT and D-1MT were added into the reaction systems, respectively, changes of T lymphocytes proliferation were detected. Real time PCR was preformed to compare the expression levels of IDOl and IDO2 genes between MSC and Stro-1 + MSC. GAPDH was used as internal reference. Re- sults: ( 1 )In various dose of cells, Stro-1 +MSC elicited significant inhibition of lymphocyte proliferation in MLR than unselected MSC (P〈 0.05); (2)The inhibitory effects of both Stro-1 +MSC and MSC decreased significantly when L-1MT was added (P〈0.05), but they did not change when D-1MT was added (P〉0.05); (3)The significant difference of the suppressive effect between Stro-1 +MSC and MSC was disappeared when L-1MT was added (P〉0.05), but it still existed when D-1MT was added (P〈0.05); (4)Real time PC R indicated that the expression level of IDO 1 gene in Stro-1+ MSC was significantly higher than that in unselected MSC (P〈0.05), but IDO2 gene expression lev- el had no significant difference between the two groups (P〉0.05). Conclusion: It is IDOl, not IDO2, that play a major role in the immuno- suppressive effect of MSC and the profound inhibition of Stro-1+MSC. Such effects can be abrogated by L-1MT, D-1MT is inefficient.
出处 《天津医科大学学报》 2012年第2期185-188,191,共5页 Journal of Tianjin Medical University
关键词 STRO-1 间充质干细胞 免疫抑制 吲哚胺2 3-二氧化酶 L-1MT Stro-1 mesenchymal stem cell immunosuppression indoleamine2,3-dioxygenase L-1MT
  • 相关文献

参考文献2

二级参考文献16

  • 1Frassoni F LM, Bacigalupo A, Gluckman E. Expanded mesenchymal stem cells (MSC), coinfused with HLA identical hemaepoietic stem cell transplants, reduced acute and chronic graft versus host disease: a matched pair analysis [abstract]. Bone Marrow Transplant, 2002,29: 75.
  • 2Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet, 2004 ,363 :1439-1441.
  • 3Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science, 1999, 284:143-147.
  • 4Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol,2000,28:875-884.
  • 5Suva D, Garavaglia G, Menetrey J, et al. Non-hematopoietic human bone marrow contains long-lasting, pluripotential mesenchymal stem cells. J Cell Physiol,2004,198:110-118.
  • 6Gotherstrom C,Ringden O, Westgren M, et al. Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells. Bone Marrow Transplantation, 2003, 32: 265-272.
  • 7Fouillard L, Bensidhoum M, Bories D, et al. Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma. Leukemia, 2003,17:474-476.
  • 8Lee HS, Huang GT, Chiang H, et al. Multipotential mesenchymal stem cells from femoral bone marrow near the site of osteonecrosis. Stem Cells, 2003, 21: 190-199.
  • 9Zhao RC, Liao LM, Han Q. Mechanisms of and perspectives on the mesenchymal stem cell in immunotherapy. J Lab Clin Med, 2004,143:284-291.
  • 10Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol, 2002,30:42-48.

共引文献17

同被引文献10

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部